期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Clinical Application of Lobaplatin Combined with Docetaxel in Adjuvant Chemotherapy for Triple-Negative Breast Cancer in Elderly Patients 被引量:1
1
作者 Weihua Jiang Li Wang +3 位作者 Yongtao Li Chenguang Zhang lina yi Jianghua Ou 《Advances in Modern Oncology Research》 2020年第1期9-13,共5页
To investigate the adverse reactions and efficacy of docetaxel combined with lobaplatin in adjuvant chemotherapy for triple-negative breast cancer in elderly patients.A total of 96 elderly triple-negative breast cance... To investigate the adverse reactions and efficacy of docetaxel combined with lobaplatin in adjuvant chemotherapy for triple-negative breast cancer in elderly patients.A total of 96 elderly triple-negative breast cancer patients admitted to our hospital from January 2008 to December 2011 were randomly divided into two groups.A group of 56 patients received docetaxel 75 mg·m^(-2),intravenous drip,d1;lobaplatin 30 mg·m^(-2),intravenous drip,d1;21 days repeat,a total of 6 cycles.A group of 40 patients received chemotherapy for 6 cycles with an anthracycline-containing(TEC)regimen.Comparison of adverse reactions and 5-year diseasefree survival in both groups.The incidence of thrombocytopenia was significantly higher in 56 patients with TL regimen than those with TCE-containing anthracyclines(P=0.005).But the incidence of cardiotoxicity was 32.5%in the TEC group.And the difference was statistically significant(P=0.008).The 5-year disease-free survival rate was 73.2%in the TL group and 67.5%in the TEC group.There was no statistical difference.Docetaxel combined with lobaplatin in the treatment of elderly triple-negative breast cancer has no significant difference in efficacy compared with traditional anthracycline-containing drugs,but it can avoid the cardiotoxicity caused by anthracyclines.It’s a new option for elderly TNBC adjuvant chemotherapy,suggesting to expand the sample content for further research. 展开更多
关键词 DOCETAXEL Lobaplatin Triple-negative breast cancer
下载PDF
The New Infinite Sequence Complexion Solutions of a Kind of Nonlinear Evolutionary Equations
2
作者 lina yi Jundong Bao   Taogetusang 《Journal of Applied Mathematics and Physics》 2015年第12期1624-1632,共9页
The method combining the function transformation with the auxiliary equation is presented and the new infinite sequence complexion solutions of a class of nonlinear evolutionary equations are constructed. Step one, ac... The method combining the function transformation with the auxiliary equation is presented and the new infinite sequence complexion solutions of a class of nonlinear evolutionary equations are constructed. Step one, according to two function transformations, a class of nonlinear evolutionary equations is changed into two kinds of ordinary differential equations. Step two, using the first integral of the ordinary differential equations, two first order nonlinear ordinary differential equations are obtained. Step three, using function transformation, two first order nonlinear ordinary differential equations are changed to the ordinary differential equation that could be integrated. Step four, the new solutions, B?cklund transformation and the nonlinear superposition formula of solutions of the ordinary differential equation that could be integrated are applied to construct the new infinite sequence complexion solutions of a class of nonlinear evolutionary equations. These solutions are consisting of two-soliton solutions, two-period solutions and solutions composed of soliton solutions and period solutions. 展开更多
关键词 NONLINEAR Evolutionary Equation Function Transformation NONLINEAR SUPERPOSITION Formula of SOLUTIONS Complexion NEW SOLUTIONS
下载PDF
Seroprevalence of human enterovirus A71 in Guangzhou,China,2019-2021 被引量:1
3
作者 Huimin Lian Huimin Jianng +10 位作者 lina yi Jing Sun Huaping Xie Ming Qiu Limei Sun Huifang Lin Mingda Yang Lin Qu Haiyi Yang Jing Lu Hanri Zeng 《Biosafety and Health》 CAS CSCD 2023年第3期168-173,共6页
Enterovirus A71 (EV-A71) is a significant hand-foot-mouth disease (HFMD) etiology. The inactivated EV-A71 vaccines were approved in China in 2016. However, the seroprevalence of EV-A71 after the vaccine application an... Enterovirus A71 (EV-A71) is a significant hand-foot-mouth disease (HFMD) etiology. The inactivated EV-A71 vaccines were approved in China in 2016. However, the seroprevalence of EV-A71 after the vaccine application and its potential association with the EV-A71 epidemic in the population are rarely studied. In this study, we analyzed the incidence of EV-A71 infection and seroepidemiology in Guangzhou City, China. From 2019 to 2021, 167,920 clinically confirmed HFMD cases were reported in Guangzhou. In 6,868 enterovirus-positive samples, Coxsackievirus A6 and Coxsackievirus A16 were dominant genotypes, and only 3 EV-A71-positive samples were detected, highlighting the deficient epidemic activity of EV-A71. Microneutralization assay was performed on 1,000 representative serum samples. Notably, the seroprevalence and geometric mean titer (GMT) decreased significantly in 2020, and that in the < 3-year age group were increased and even higher than that in 3–5-year age group in 2019 and 2021, which was contrary to our previous surveillance result and other studies in Guangzhou. Furthermore, a moderate decline of GMT level was observed following the vaccination, but the seropositive serums were still detected for 49 months after second immunization, suggesting the long-term persistence of the immunity. Our seroepidemiology study revealed relatively higher neutralizing antibody activity in the susceptible population after the EV-A71 vaccine was adopted in 2016 in Guangzhou. It may be one of the reasons for the lower epidemic activity of EV-A71 in Guangzhou from 2019 to 2021. 展开更多
关键词 Enterovirus A71 VACCINE SEROEPIDEMIOLOGY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部